Q.1
How would you now rate your level of understanding of the risk factors, diagnosis, screening strategies and, treatment of CKD?

Q.2
Which patients do you believe are at risk of developing CKD?

Q.3
Do you currently screen your at-risk patients for CKD or will you regularly screen your at-risk patients from now on?

Q.4
Please rate your current level of confidence when selecting treatments for CKD patients?

Q.5
How would you rate your knowledge of the latest data from clinical trials of SGLT2i, GLP-1 RA, and DPP4?

1 / 5